$347 Million is the total value of New Leaf Venture Partners, L.L.C.'s 22 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 26.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | Sell | ARVINAS INC | $107,507,000 | -36.9% | 1,308,187 | -40.9% | 31.01% | -29.1% |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $41,101,000 | +24.0% | 1,209,571 | 0.0% | 11.86% | +39.4% | |
| New | RALLYBIO CORPORATION | $40,462,000 | – | 2,301,603 | +100.0% | 11.67% | – | |
| EWTX | EDGEWISE THERAPEUTICS INC | $25,791,000 | -41.1% | 1,553,661 | 0.0% | 7.44% | -33.8% | |
| HARP | HARPOON THERAPEUTICS INC | $24,938,000 | +641.3% | 3,156,699 | 0.0% | 7.19% | +733.5% | |
| PASG | PASSAGE BIO | $24,879,000 | +1591.3% | 2,497,922 | 0.0% | 7.18% | +1798.4% | |
| New | DICE THERAPEUTICS INC | $18,232,000 | – | 556,693 | +100.0% | 5.26% | – | |
| SRRA | SIERRA ONCOLOGY INC | $8,979,000 | +120.8% | 409,611 | 0.0% | 2.59% | +148.1% | |
| ALEC | ALECTOR INC | $7,749,000 | +9.6% | 339,569 | 0.0% | 2.24% | +23.1% | |
| APTX | APTINYX INC | $7,699,000 | -17.3% | 3,290,079 | 0.0% | 2.22% | -7.1% | |
| CMRX | CHIMERIX INC | $7,580,000 | -22.6% | 1,224,600 | 0.0% | 2.19% | -13.1% | |
| New | RENOVACOR CORPORATION | $6,312,000 | – | 697,436 | +100.0% | 1.82% | – | |
| AMYT | New | AMRYT PHARMA PLC | $5,417,000 | – | 449,737 | +100.0% | 1.56% | – |
| COGT | COGENT BIOSCIENCES INC. | $4,218,000 | +58.7% | 501,530 | 0.0% | 1.22% | +78.4% | |
| ARAV | ARAVIVE INC | $3,521,000 | -37.8% | 946,423 | 0.0% | 1.02% | -30.1% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $2,968,000 | -93.3% | 141,000 | 0.0% | 0.86% | -92.5% | |
| OBSV | OBSEVA SA | $2,801,000 | -91.5% | 900,501 | 0.0% | 0.81% | -90.5% | |
| XFOR | X4 PHARMACEUTICALS INC | $1,772,000 | -18.6% | 335,000 | 0.0% | 0.51% | -8.6% | |
| AVRO | AVROBIO INC | $1,761,000 | -37.2% | 315,550 | 0.0% | 0.51% | -29.4% | |
| PDSB | PDS BIOTECHNOLOGY CORP | $1,747,000 | -78.1% | 117,242 | 0.0% | 0.50% | -75.4% | |
| ITRM | ITERUM THERAPEUTICS PLC | $813,000 | -70.2% | 1,456,303 | 0.0% | 0.23% | -66.6% | |
| ADXN | ADDEX THERAPEUTICS LTD | $451,000 | -5.6% | 50,000 | 0.0% | 0.13% | +5.7% | |
| CHMA | Exit | CHIASMA INC | $0 | – | -1,135,700 | -100.0% | -1.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.